Table 3.
Compound | Antiviral activity: EC50a (μM) |
Cytotoxicity: MCCb (μM) | |||||
---|---|---|---|---|---|---|---|
Para-influenza-3 virus | Reovirus-1 | Sindbis virus | Coxsackie B4 virus | Punta Toro virus | Yellow fever virus | ||
1 | >100 | >100 | >100 | >100 | >100 | >100 | >100 |
2 | >100 | >100 | >100 | >100 | >100 | >100 | >100 |
3 | >100 | >100 | >100 | >100 | >100 | >100 | >100 |
4 | >100 | >100 | >100 | >100 | >100 | >100 | >100 |
5 | >100 | >100 | >100 | >100 | >100 | >100 | >100 |
6 | >100 | >100 | >100 | >100 | >100 | >100 | >100 |
7 | >100 | >100 | >100 | >100 | >100 | >100 | >100 |
8 | >100 | >100 | >100 | >100 | >100 | >100 | >100 |
9 | >100 | >100 | >100 | >100 | >100 | >100 | >100 |
10 | >100 | >100 | >100 | >100 | >100 | >100 | >100 |
11 | >100 | 6.8 | >100 | >100 | >100 | >100 | ≥100 |
12 | >100 | 9.5 | >100 | >100 | >100 | >100 | >100 |
13 | >100 | 2.1 | >100 | >100 | >100 | >100 | >100 |
14 | >100 | 6.8 | >100 | >100 | >100 | >100 | ≥100 |
15 | >100 | >100 | >100 | >100 | >100 | >100 | >100 |
16 | >100 | 3.8 | >100 | >100 | >100 | >100 | ≥100 |
17 | >100 | >100 | >100 | >100 | >100 | >100 | >100 |
18 | >100 | >100 | >100 | >100 | >100 | >100 | >100 |
19 | >100 | >100 | >100 | >100 | >100 | >100 | >100 |
20 | >100 | >100 | >100 | >100 | >100 | >100 | >100 |
21 | >100 | >100 | >100 | >100 | >100 | >100 | >100 |
22 | >100 | >100 | >100 | >100 | >100 | >100 | >100 |
23 | >100 | >100 | >100 | >100 | >100 | >100 | >100 |
24 | >100 | >100 | >100 | >100 | >100 | >100 | >100 |
25 | >100 | >100 | >100 | >100 | >100 | >100 | >100 |
26 | >100 | >100 | >100 | >100 | >100 | >100 | >100 |
27 | >100 | >100 | >100 | >100 | >100 | >100 | >100 |
28 | >100 | >100 | >100 | >100 | >100 | >100 | >100 |
29 | >100 | >100 | >100 | >100 | >100 | >100 | >100 |
30 | >100 | >100 | >100 | >100 | >100 | >100 | 20 |
31 | >100 | >100 | >100 | >100 | >100 | >100 | >100 |
32 | 20 | 5.4 | 8.9 | 46 | >100 | >100 | ≥20 |
33 | >100 | >100 | >100 | >100 | >100 | >100 | >100 |
DS-10,000c | >100 | >100 | 2.3 | 2.3 | 45 | 0.40 | ≥100 |
Ribavirin | 112 | >250 | >250 | >250 | 29 | >250 | >250 |
Mycophenolic acid | 0.40 | 1.8 | 1.4 | >100 | 20 | 2.3 | >100 |
EC50: 50% effective concentration producing 50% inhibition of virus-induced cytopathic effect (CPE), as determined by microscopy.
MCC: minimum compound concentration producing a microscopically detectable alteration in normal cell morphology.
For DS-10,000 (dextran sulphate of MW 10,000) concentrations are in μg/ml. Values shown are the mean of two determinations.